Mark Klang

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Targeting AMP kinase in melanoma: A phase I trial of phenformin with dabrafenib/trametinib.”.

Targeting AMP kinase in melanoma: A phase I trial of phenformin with dabrafenib/trametinib.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9536

N/A

0.115DataRank · unranked

1 citations

Mark Klang, Michael A. Postow, Alexander N. Shoushtari, Ryan J. Sullivan, Jedd D. Wolchok +4 more

A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation

Cancer(2022)10.1002/cncr.34444

N/A

0DataRank · unranked

19 citations

Gunjan L. Shah, Peter Adintori, Andrea Knežević, Sean M. Devlin, Marissa L. Buchan +22 more

Keratinocytes coordinate inflammatory responses and regulate development of secondary lymphedema

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.20.524936

N/A

0DataRank · unranked

2 citations

Raghu P. Kataru, Jinyeon Shin, Gabriela D. García Nores, Elizabeth Encarnacion, Mark Klang +5 more

TGF-β–mediated epithelial-mesenchymal transition of keratinocytes promotes fibrosis in secondary lymphedema

JCI Insight(2025)10.1172/jci.insight.192890

N/A

0DataRank · unranked

9 citations

Jinyeon Shin, Ananta Sarker, Mark Klang, Elyn Riedel, Michelle Coriddi +5 more